SFM
FBRX

Sphera Funds Management’s Forte Biosciences FBRX Stock Holding History

Sphera Funds Management’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.31M Buy
249,693
+64,709
+35% +$1.53M 0.69% 48
2026
Q1 		$4.79M Sell
184,984
-885
-0.5% -$25.5K 0.76% 47
2025
Q4 		$5.07M Sell
185,869
-288,440
-61% -$5.06M 0.98% 43
2025
Q3 		$7.11M Sell
474,309
-20,800
-4% -$240K 1.5% 18
2025
Q2 		$6.4M Buy
+495,109
New +$4.26M 1.5% 19
2019
Q2 		– Sell
-320
Closed -$1.3M – 97
2019
Q1 		$1.3M Buy
+320
New +$1.24M 0.12% 89

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Sphera Funds Management's FBRX Position: Q2 2026 in Review

Sphera Funds Management increased its Forte Biosciences (FBRX) stake by 35% in Q2 2026, buying an estimated $1.53M and bringing the position to 249,693 shares worth $5.31M. The position accounts for 0.69% of the portfolio, ranked #48.

Sphera Funds Management first reported a position in FBRX in Q1 2019 and has held it in 6 quarters since. The position peaked at $7.11M in Q3 2025. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Sphera Funds Management held 249,693 shares of Forte Biosciences worth $5.31M as of Q2 2026.
  • Sphera Funds Management bought 64,709 Forte Biosciences shares in Q2 2026, an estimated $1.53M.
  • Forte Biosciences made up 0.69% of Sphera Funds Management's portfolio in Q2 2026, its #48 holding.
  • Sphera Funds Management first reported a position in Forte Biosciences in Q1 2019 and has held it in 6 quarters since.
  • Sphera Funds Management's Forte Biosciences position peaked at $7.11M in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.